Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Kazia Licenses Cantrixil, a Clinical-stage, First-in-class Ovarian Cancer Drug Candidate, to Oasmia Pharmacetical AB 2021-03-02 07:00
INOVIO Announces Positive Results from REVEAL 1, a Phase 3 Pivotal Trial Evaluating VGX-3100, its DNA-based HPV Immunotherapy for the Treatment of High-grade Precancerous Cervical Dysplasia Caused by HPV-16 and/or HPV-18 2021-03-02 05:05
China Biologic Announces Shareholders' Approval of Merger Agreement 2021-03-01 21:00
Medilink Therapeutics Raises $50 Million in Series A Financing To Accelerate Next-Generation Conjugated Drugs Research & Development 2021-03-01 19:50
CARsgen Therapeutics Receives Orphan Medicinal Product Designation from the European Medicines Agency for CT041 CLDN18.2 CAR T Cells for the Treatment of Gastric Cancers 2021-03-01 19:00
Merck Builds on Leadership in Head and Neck Cancer Through Worldwide Licensing Agreement with Debiopharm for Pivotal-Stage Xevinapant 2021-03-01 18:48
Avalon SteriTech and SoftBank Robotics Group Launch New Joint Venture to Develop and Promote Innovative Public Healthcare and Hygiene Solutions 2021-03-01 13:00
Sciwind's Investigational New Drug Approved for NASH Trial 2021-03-01 09:00
Innovent Announces First Patient Outside China Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody 2021-03-01 08:23
Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index 2021-03-01 08:00
Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index 2021-03-01 08:00
Alterity to present at the 7th International Congress of Multiple System Atrophy 2021-02-26 20:45
Debiopharm And Genome & Company Join Forces To Create New Highly Specific Therapies For Cancer Patients 2021-02-26 19:14
Biocytogen announces acquisition of a third Beacon Optofluidic system to support expanding Antibody Discovery Platform 2021-02-25 23:45
Genome & Company and Debiopharm Join Forces To Create New Highly Specific Therapies for Cancer Patients 2021-02-25 07:00
Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2021 2021-02-25 05:16
Zymergen Appoints Global Finance Expert Enakshi Singh as Chief Financial Officer 2021-02-24 22:30
VLP BioTech, Inc. Announces an Immunotherapy Designed for the Treatment of Chronic HBV/HDV Infections 2021-02-24 22:00
INOVIO and QIAGEN expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO's VGX-3100 for advanced cervical dysplasia 2021-02-24 14:45
Alternative meat startup Next Meats Co., Ltd and microalgae biotech company euglena Co., launch "NEXT Euglena Yakiniku EX" containing microalgae 2021-02-24 12:45
1 220 221 222 223 224 415